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Summary 
We have tested the ability of the T  cell receptor/3 (TCR-B) transcriptional  enhancer (E~) to 
confer transcriptional  activation and tissue-specific V(D)J recombination of TCR-~ V, D, and 
J  segments  in a transgenic  minilocus  recombination substrate.  We find that the minimal E~ 
element, as previously shown for a DNA segment that contained the E/~ element, promotes 
a high level of substrate D  to J~ rearrangement in both B and T cells, but only promotes Va 
to DJ~ rearrangement in T  cells, Thus, both the E~ and E~ elements  similarly direct  V(D)J 
recombination of this substrate in vivo, supporting a general role for transcriptional  enhancers 
in the normal regulation of this rearrangement process. Surprisingly, however, we found that 
both the V~ and DJ~ portion of the constructs were transcribed  in an enhancer-dependent 
fashion (conferred by either E~ or E0) in both B and T lineage cells, including normal precursor 
B cells propagated in culture. These findings indicate that, at least in some contexts, transcriptional 
activation, per se, is not sufficient to confer V(D)J recombinational  accessibility to a substrate 
V  gene segment. 
T 
he genes that encode the variable regions of Ig and TCRs 
are assembled from germline V, D, and J gene segments 
by a process referred to as V(D)J recombination (1). Both 
Ig and TCR variable region gene segments are assembled by 
a common V(D)J recombination activity during the precursor 
(pre-) stages of B and T  cell differentiation.  Within pre-B 
and pre-T cell populations,  the V(D)J recombination pro- 
cess is controlled in several  contexts including lineage-specificity 
(e.g., complete assembly of Ig variable region genes in B cells 
but not T cells), developmental  stage-specificity  (e.g., assembly 
of Ig heavy chain variable region genes before those of Ig 
light chains), and allelic exclusion (reviewed by [2-5]). Since 
there is a common VDJ recombinase, the regulation of Ig 
or TCR gene segments that are assembled in particular cells 
and  stages within lymphoid lineages must be effected by 
modulating the accessibility of substrate gene segments to 
the recombinase  (6). 
V(D)J recombinational  accessibility of both Ig and TCR 
variable region gene segments  has been correlated with a 
number of factors including their transcriptional  activity 
(7-12). Direct evidence that transcriptional control elements 
or closely associated sequences can function in cis to promote 
V(D)J recombinational accessibility was provided by a trans- 
genic recombination substrate analyses  (9). These studies em- 
ployed a TCR-B minilocus transgene (VDJ~Cu substrate; see 
Fig. 1) that lacked known transcriptional enhancer elements 
and that was neither transcribed nor rearranged in lymphoid 
or non-lymphoid tissues. However, addition of a DNA seg- 
ment that contained  the intronic Ig heavy chain enhancer 
(E~) element (V~DJ~E~C  u substrate;  see Fig.  1) promoted 
efficient D  to  Jo  construct  rearrangements in  most  de- 
veloping lymphocytes. 
Various lines of evidence  indicate that, for both Ig and TCR 
loci, V to DJ rearrangements are the most stringently regu- 
lated event in the V(D)J recombination process (4, 5, 13, 14). 
In this context, the transgenic VDJ~E~C~ minilocus studies 
also provided evidence for tissue specific elements that con- 
trol the V~ to DJ~ rearrangement step. Thus, although this 
transgene underwent D  to J~ rearrangements  in most de- 
veloping B and T cells, construct Va to DJ~ rearrangements 
were almost exclusively  limited to T lineage cells (9). There- 
fore,  additional  elements  within this construct appear to 
differentially control accessibility of the construct V~ gene 
segment in T vs. B cells. Similar specificity of rearrangement 
also was observed with an independent TCR-~ transgenic 
recombination substrate  (15). 
The exact mechanism by which transcriptional  control 
elements function to confer V(D)J recombinational accessi- 
bility remains unclear. In particular,  a continuing question 
has been whether transcription  per se of V gene segments 
is sufficient to generate their recombinational accessibility in 
developing lymphoid cells. The strict enhancer dependence 
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rangements of the TCR-fl minilocus recombination substrate 
provides a model system for in depth studies of the molec- 
ular mechanisms of these processes in normal developing lym- 
phocytes. Thus,  we have now addressed these issues by as- 
saying  for  the  ability  of  an  unrelated  lymphoid-specific 
enhancer,  the minimal  TCK-fl enhancer  (E~),  to promote 
rearrangement of the V~DJoC~ minilocus and by comparing 
the transcriptional  activity of the V~  and DJ~ portions  of 
the various versions of this substrate in developing B and T 
lineage cells. 
Materials and Methods 
Substrate Construction.  The recombination substrate  VDJEaC~ 
was assembled  from genomic DNA fragments encoding TCR-~3 
V~14, Dal.1, Jt~l.1, and 1.2, TCR-/3 enhancer,  and the C~ regions 
as previously described (9, 16) except that the 1.1-kb NaeI-EcoRI 
IgH  enhancer  fragment  of  the  VDJaE~C~ construct  (9)  was 
replaced with the 560-bp NcoI-HpaI fragment containing the rou- 
tine TCR-B enhancer (see Fig.  1). 
Generation and Analysis of Transgenic  Mic~  Transgenic mice were 
generated by injection of the VDJoEaC~ construct into B6/CBA 
x  B6/CBA F1 zygotes as described previously (9). Integration and 
copy number of transgenic constructs in the various mice was de- 
termined by quantifying the level of the 6-kb Va14-hybridizing 
BgllI fragment specific for the transgene by Southern blotting anal- 
yses of tail  or tissue  DNA (see Fig.  2).  The transgenic founder 
mouse no. 5 harbored two independently segregating integrants 
of the construct, which were propagated as lines no. 5 (60 copies) 
and 5.1 (5 copies); founder mouse no. 2 was propagated to estab- 
lish line 2 (25 copies).  Founder no. 6 carried one to two copies 
of the construct in all analyzed tissues,  but did not transmit the 
gene to >50 offspring analyzed. This mouse was killed at 6 mo 
of age for analysis. 
B and T cellpurification.  B and T cells were purified from trans- 
genic mice by the "panning" procedure (17). B cells were isolated 
as cells adherent to 10-cm polystyrene bacterial petri dishes (Fisher 
Scientific Co., Pittsburgh, PA) coated with 250 ng/ml polyclonal 
goat anti-mouse Ig(G+A+M) (Zymed Laboratories, Inc., S. San 
Francisco, CA); T cells were isolated as nonadherent cells after two 
rounds  of incubation  on  plates  coated  with  10  #g/ml  goat 
anti-mouse Ig(G+A+M). B cells were 95 to 98% pure, as deter- 
mined by FACS  |  analysis (FACScan|  Becton Dickinson & Co., 
Mountain View, CA) using FITC-conjugated rat anti-mouse B220 
and PE-conjugated rat anti-mouse CD5 or a combination of PE- 
conjugated  rat  anti-mouse  CD4  and  FITC-conjugated  rat 
anti-mouse CD8 (PharMingen, San Diego, CA) (data not shown). 
T cells were 80-95% depleted of B cells as determined by FACS  | 
analysis (40-90%  CD5 + cells, depending on  the non-T,  non-B 
cells in the starting population). 
Establishment and Analysis of Lymphoid Bone Marrow Culture 
(LBMC)L  Pre-B cell cultures were established from bone marrow 
of 3-6-wk-old mice as described previously (18, 19). After 3-4 wk, 
nonadherent cells were harvested from the cultures for analysis, 
or 250 U/ml of recombinant human IL-7 was added to the cultures 
1Abbreviation used in this  paper: LBMC, lymphoid bone marrow culture. 
to expand pre-B cells (gift of Stephen GiUis; Immunex Corp., Seattle, 
WA [20, 21]). After 1 wk in IL-7-supplemented medium, the non- 
adherent cells were harvested and contaminating adherent stromal 
cells were removed by incubating the cells on fresh plates for 24 
h. Analyzed cells represented pre-B cells based  on expression  of 
characteristic surface markers (BPI*/CD43 +/B220 +/slg- ; [22]) 
as determined by FACS  |  analyses after staining with FITC- or PE- 
conjugated, monoclonal rat anti-mouse BP1, CD43, B220, or IgM 
(PharMingen), as well as by RAG-l, RAG-2, and ~5 expression 
as determined by Northern blot analyses (23). 
A-MuLV-transformed Cell Lines.  A-MuLV  transformation  of 
adult bone marrow was performed as described  previously (24). 
The cell lines represented the pre-B stage as determined by surface 
expression  of B220 on early passages of the cells, rearrangement 
of endogenous IgH loci, and expression  of RAG-1 and -2 tran- 
scripts  (data  not shown). 
Southern Blotting Analysis.  Genomic DNA was prepared from 
tissues and cell lines, digested with BgllI and analyzed by Southern 
blotting procedures as previously described (9, 16). The VDJaEaC~ 
transgenic line 5 had aberrant integrations resulting in bands that 
migrate with rearranged products, and could not be clearly ana- 
lyzed for V(D)J rearrangement by Southern blotting. Therefore, 
this line was primarily analyzed by PCR methods. Quantitation 
of Southern blots were performed either on a phosphorimager or 
densitometer (Molecular Dynamics Inc., Sunnyvale,  CA). 
PCR Analysis.  PCR analysis of the samples were performed 
as previously described using Amplitaq DNA polymerase (Perkin- 
Elmer Cetus, Norwalk, CT) (25). Rearrangements in B and T cells 
were assayed by amplification at: 92~  1 min; 55~  2 min; 72~ 
3 rain for 32 cycles. Rearrangements in A-MuLV-transformed cells 
and LBMC were examined after amplification at:  92~  1 rain; 
55~  2 min; 72~  3 min for 40 cycles to detect low frequency 
V(D)J rearrangements.  Oligonucleotide primers to detect rearrange- 
ments  were:  5'D0:  5'-GTGAAGCTTCCTTCCTTATCTTCA- 
ACTC-3'; TCR-~: 5'-GGAATTCTATATCTCTTqGCTGGAATC- 
3'; 5'C~: 5'-TCGGAATTCGGGTATTGGAAAATAATT-Y; V~14: 
5'-TCTAAGCTTAAATCAAGCCCTAACCTCTAC-3'. To detect 
D-J rearrangements, 5'D0 and 5'C~ (primer set  1DJ) or TCR-/~ 
(primer set 2DJ) oligos were used. To detect V(DJJ rearrangements, 
V~14 and 5'C~ (primer set  1VDJ) or TCR-/8 (primer set 2VDJ) 
oligos were used.  PCR-amplified products using 5'Do and 5'C~ 
or V014 and 5'C~ were analyzed after BamHI digestion, to allow 
better resolution of the products by gel-electrophoresis.  Amplified 
products were separated  on a 1.4%  Tris-borate  buffered agarose 
gel, transferred onto zeta-probe membrane (Bio-Rad Laboratories, 
Inc., Richmond, CA) by alkaline transfer and assayed for hybrid- 
ization to an  oligonucleotide probe to Jo2  (5'-AAAGCCTGG- 
TCCCTGAGCCGA-3') as previously described (25). 
$1 Nuclease Protection Assay.  DNA fragments used to generate 
$1 nuclease protection probes were cloned into pBluescript SK II 
(Stratagene,  La Jolla,  CA).  3~p-radiolabeled probes  were subse- 
quently generated by in vitro transcription using T3 or T7 poly- 
merase (Stratagene),  as previously described (26).  The Va14 $1 
probe was previously described  (9). The D-Jo region probe spans 
the XbaI-EcoRI fragment from the VDJoE~C/z construct. The 
GAPDH probe was made from amplifying position 945-1261 of 
GAPDH  from  murine  liver cDNA  by PCR  and  cloning  the 
amplified fragment into pBluescript SKII (Stratagene)  (Zhang, J., 
E. Ohz, and F. Ah, unpublished data and reference 27). Approxi- 
mately 2-50/zg of total RNA was hybridized to the probes, digested 
with S1 nuclease  and resolved on a denaturing acrylamide gel as 
previously described (9). Yeast tRNA (10 #g) was added to reac- 
tions that employed lower amount (2/~g) of cellular  RNA. 
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Generation of VDJz?E~C.~, Transgenic Mice.  We generated 
the VDJaEaCu recombination substrate by adding a 560 bp 
DNA segment that contained the minimal E~ element to 
the same site of the VDJaC~  substrate that we previously 
added  the  1126bp  E~,-containing  fragment  to  create  the 
VDJ~E~,C~ construct (Fig.  1). Three VDJ~E~C~, transgenic 
lines were established that, based on Southern blotting anal- 
yses  of BgllI-digested DNA  for  hybridization  to  a  V~- 
specific probe, contained ',~25 (line 2), 60 (line 5), and 5 (line 
5.1) copies of the construct (Table 1 and Fig. 2 B). Trans- 
genic founder mouse no. 6 carried a low copy number of 
the construct in all analyzed  tissues (Table 1 and Fig. 2 B) 
but did not transmit the gene. Therefore, this animal was 
sacrificed at 6 mo of age for analysis. Lines 5, 5.1, and 2 also 
harbored incomplete integrations of the transgenes that were 
evident as V~-specific BgllI fragments of unpredicted sizes 
(see below) that were unique to each line (Fig. 2; bands denoted 
with asterisks). The hybridization intensity of these fragments 
did not change in the various studied tissues (i.e., lymphoid 
vs. nonlymphoid); therefore they appear to be inactive with 
respect to recombination and were not further characterized. 
The E~ Element Promotes V(D)J Recombinational Accessi- 
bility.  DNA from various tissues of the VDJaEaC~ trans- 
genic mice was digested with BgllI and analyzed for con- 
struct rearrangements by Southern blotting using a probe 
specific for Vfi14 (Fig.  2 A; reference 9). This analysis de- 
tects the unrearranged, DJ-rearranged, and VDJ rearranged 
VDJaE~G, transgenes as V~14-hybridizing BgllI fragments 
of 5.5, 10.5, and 6.5 kb, respectively; whereas the endoge- 
nous Va gene yields a 3.7 kb hybridizing fragment (Fig. 2 
A). We detected construct DJ and V(D)J rearrangements at 
substantial levels in DNA from thymus of all VDJ~E~C~ 
transgenic lines and at somewhat lower, but still significant, 
levels in DNA from lymph nodes and spleen; a low level of 
construct DJ  rearrangements was also  detectable  in bone 
marrow of these lines (Fig. 2 B, Table 1, and data not shown). 
No significant rearrangement of the construct was observed 
in DNA from nonlyrnphoid tissues beyond the very low levels 
attributable to circulating lymphocytes (Fig. 2 B; representa- 
tive data is shown). 
The pattern and relative extent of DJ and V(D)J rearrange- 
ments of the VDJ~EoCu transgenes was similar to that pre- 
viously observed for the VDJ~E~C~ transgenic lines (9) (rep- 
resentative data for VDJ~E~C~ Iines 382 and 379 are shown 
in Fig. 2, B and C). Significantly, we cannot detect rearrange- 
ment of the VDJaC~  construct, which lacks a known en- 
hancer element (Fig. 1), in either lymphoid or nonlymphoid 
tissues of six independent lines of transgenic mice (reference 
9; also, see Fig.  2 C; line 1016). Thus physical linkage of 
a DNA fragment containing the E~ element, like the E~ ele- 
ment, targets the associated TCR-fl V, D, and J  segments 
for V(D)J recombination. 
T  Cell-specific V  to DJ Rearrangement of the VDJz?Ez~C~ 
Transgene.  We previously observed D  to J rearrangements 
of the VDJaE~C~ transgene in both B and T  lineage cells 
but found construct VDJ rearrangements only in T cells (9). 
To assay for DJ versus VDJ rearrangement of the VDJaE~G, 
substrate in B versus T  cells, we used panning procedures 
to purify splenic and lymph node B and T  cells from the 
four VDJ~EaC~, lines and the 382 VDJaE~,C~ line; purified 
B cells were greater than 95% pure as determined by FACS  | 
analysis, while T calls were 80-95% depleted of B ceils (data 
not shown). DNA isolated from purified B and T cells was 
assayed for rearrangement of the transgenic substrate by a 
PCR. assay that employed primer combinations that specifically 
detect minilocus DJ and VDJ rearrangements (Fig. 3 A). DNA 
concentration and the efficiency  of the PCtL reaction was con- 
trolled by examining the PCR amplification of a separate DNA 
fragment in the same reaction (Fig. 3 A; legend). In addi- 
tion, the level of rearrangement in thymic DNA of a given 
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Figure  1.  TCR-•  minilocus 
recombination substrates.  Partial 
restriction maps  of the TCIK-B 
minilocus  recombination  sub- 
strates  that contained either no 
enhancer  (VDJaCa),  a  560  bp 
DNA  fragment  that  contains 
the minimal  TCR-/~  enhancer 
(VDJ~E~3C~) or an 1126-bp DNA 
fragment  that  contains  the  E~ 
element  (VDJ~E~C~).  Restric- 
tion endonuclease site are indicated 
as follows: RI, EcoRl; PI, PvuI; 
BII, BgllI; Barn, BamHI. Known 
DNA motifs important for tran- 
scriptional enhancement are shown 
in the Ea element (31, 54).  The 
/xEBP-E element is also found out- 
side  of the core Eu elements as 
indicated (30, 31). Note that the 
inserted elements are drawn on a 
different scale than the base con- 
struct. 
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 Figure  2.  Southern  blot anal- 
ysis of construct rearrangements. 
(A)  Schematic of unrearranged 
DJ or VDJ rearranged miniloci. 
Arrows represent BgllI restriction 
sites within the miniloci; squares 
represent  variable region gene 
segment or C  a region; triangles 
represent recombination  signal se- 
quences. The probe used is indi- 
cated and represents the 670-bp 
Accl  fragment  spanning  the coding 
and 3' regions of Va14 (16). The 
sizes of  BgllI fragments resulting 
from  V(D)J rearrangements of 
VDJ~EaC~, that hybridize to the 
probe are denoted; the size  of  rear- 
rangements of VDJaEuCu are de- 
noted in parentheses. (/3) Southern 
blot analysis  of substrate rearrange- 
ments  in  transgenic mice. Ge- 
nomic  DNA (10/xg) isolated  from 
denoted tissues of nontransgenic 
(lanes I  and 2), VDJaE~,C  u line 
379 (lane 3), and VDJoEaC~ line 
2 (lanes 4-9),  VDJaEaC~ trans- 
genic mouse 6 (lanes 10-14) and 
VDJaEaC~ line 5.1 (lanes 15-I8) 
was digested with BgllI and ana- 
lyzed  by Southern blotting for hy- 
bridization to the 32p-radiolabeled 
V~14 probe. Transgene-derived 
bands that correspond to unrear- 
ranged Va14 segments, DJ rear- 
rangements, and VDJ rearrange- 
ments, as well as the band that 
corresponds to the unrearranged 
endogenous Va14 segment, are 
indicated. Asterisks indicate bands 
that derive from aberrant integra- 
tions of  the construct. LN, lymph 
node,  Spl, spleen,  BM,  bone 
marrow. Note that the absolute 
levels of detected rearrangements 
in DNA from LN and Spl from 
some lines is variable, generally 
due to the proportion of  nonlym- 
phoid cells in these tissues. (C) 
Southern blot  analysis of DNA 
from LBMC and A-MuLV-trans- 
formed cell lines generated from 
transgenic mice. DNA isolated 
from LBMC generated from the 
VDJaEuC  ~ transgenic line 382 (lane 3) and VDJ,  Et~C~ line 5.1 (lane 6), and A-MuLV transformed cell lines generated from lines 382 (lane 9), 5.1 
(lanes 12-14) and VDJaC~ line 1016 (lanes I7-19) are compared with DNA isolated from thymus (lanes 1, 4, 7, 10, and 15) and liver (lanes 2, 5, 6, 
8,  11, and 16) of respective transgenic lines by Southern blot analysis as described in B (See Table 1). 
line was used as a  standard to estimate the relative level  of 
rearrangements in DNA from purified B and T  cells  of that 
line whereas liver DNA from the line was used as a "nega- 
tive" control.  We note  that  even though such PCR assays 
are only considered "semiquantitative",  we obtained results 
quite consistent with those obtained by the more quantita- 
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tive Southern blotting assay.  However,  the absolute detec- 
tion level of the  PCR  assay is  at least  10-fold greater. 
We detected no DJ or V(D)J construct rearrangements by 
this  sensitive PCR assay in either  thymic or splenic DNA 
of mice transgenic for the VDJoC~ construct (Fig. 3 B, line 
1010).  In VDJoE~C~ and VDJoE~C~ lines,  we detected levels Figure  3.  PCR analysis of construct rearrangements. (A). Schematic for primers used to detect substrate rearrangements.  Primer set 1DJ (top and 
middle) and 1VDJ (bottom) and primer set 2DJ (top and middle) and 2VDJ (bottom) were designed to specifically amplify recombination substrate sequences. 
Diagrams depict rearrangement toJ~l.1. Arrows depict BamHI sites in the substrate and amplified products. Primer set I was used to detect rearrange- 
ments of transgenic recombination substrates VDJaEaC~  (line 382) or VDJ~sC~ (lines 1010 and 1016). Amplified products from PCR of DJ and V(D)J 
rearrangements using primer set 1 were digested with BamHI before analysis. Primer set 2 was used to detect rearrangements from genomic DNA 
with transgenic substrate VDJaEt~C~ (mouse 6, lines 2, 5, and 5.1). Amplified products obtained with either set of primers were analyzed by Southern 
blot for hybridization to an 01igonucleotide  probe to Jt~l.2. Predicted BamHI-digested amplified  products of D~ to J~1.1 and Jt~l.2 rearrangements 
using primer set 1DJ (top and middle diagrams) result in hybridizing bands of 450 and 250 bps, respectively;  a 1.1-kb BamHl-digested PCR product 
of an unrearranged substrate also is detected. BamHl digested PCR products of substrate V(D)J rearrangements using primer set 1VDJ result in products 
of 470  and 330 bps (bottom). PCR using primer set 2DJ of VDJ~EaC~  substrate  result in amplified products of 520 and 380 base pairs for DJt~l.1 
and DJal.2 rearrangements, respectively, and 1.2 kb for unrearranged substrate  (top and middle). Amplification of VDJt~EaC, V(D)J rearrangements 
using primer set 2VDJ result in products of 470 and 330 bps (bottom). (B)  Rearrangement of recombination substrates  in purified B and T  cells of 
transgenic mice. 0.5/zg of genomic DNA from transgenic mouse no.  6,  and lines 2, 5,  5.1, 382,  and 1010 were analyzed by PCR for DJ and VDJ 
rearrangement of the transgenic recombination substrate as described above. PCR products of DJ and V(D)J rearrangements are shown.  PCR to detect 
DJ and VDJ rearrangements for all samples of each line were performed in parallel, using the same DNA sample in appropriate reactions.  The level 
of relative rearrangement in the samples should be compared to thymus for each line.  Thymus DNA for each transgenic line was diluted into liver 
DNA and amplified in parallel with DNA from B and T  cells, since different  copy numbers of the recombination substrate affects the sensitivity of 
the PCR assay for each transgenic line.  Amplification of unrearranged substrate using primer set 1DJ and set 2DJ or coamplification of a segment 
of an unrelated gene for lines 2, 5.1,  and 1010 (precursor lymphocyte-specific regulatory light chain [PLR/.C]  [551; data not shown)  were used to 
demonstrate equal efficiency within each set of amplification reactions.  (C) Rearrangement of recombination substrates in LBMC generated from trans- 
genic mice.  PCR were performed on genomic DNA from denoted sources as described  in B.  Reactions of each set were determined to be equally 
efficient by amplifying genomic sequence from PLRLC simultaneously (data not shown). (D) Rearrangement  of recombination substrates in A-MuLV-trans- 
formed pre-B cell lines generated from transgenic mice. PCRs were performed on 0.5/zg of genomic DNA from denoted sources as described in B. 
PLRLC sequences were amplified simultaneously,  showing that samples in each set of reactions were amplified with equal efficiency (data not shown). 
of construct  DJ rearrangements  in DNA  from  purified pe- 
ripheral B  cells (Fig. 3  B,  lane 6) and T  cells (Fig. 3 B,  lane 
7) that were usually comparable in magnitude  to the levels 
found  in  the  corresponding  thymic  DNA  (Fig.  3  B,  lanes 
1-3).  However,  in  all tested  lines,  V  to  DJ  rearrangement 
of the  VDJt~EaC~  and  VDJaE,C~,  transgene  were  found  at 
substantial levels in peripheral T  cells (Fig. 3 B, lanes 7), but 
were nearly undetectable in DNA  from peripheral B cells (Fig. 
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100x  less than that of the corresponding thymus) of D-J 
and V(D)J rearrangements in liver DNA of mice transgenic 
for VDJoEaC, and VDJoE~C~ (Fig. 3, B and C, lane 4) that 
likely result from circulating lymphocytes. Therefore, we con- 
clude that the 560-bp minimal EO element targets rearrange- 
ment of this recombination substrate with a tissue-specific 
profile similar to that  observed in the context of the E# 
element. 
To confirm that the lack of construct V(D)J rearrangements 
observed in peripheral B cells was also  a characteristic  of 
pre-B cells, we assayed  for construct rearrangements in LBMC 
pre-B cells and in A-MuLV transformed cell lines established 
from the various transgenic mouse lines. Long-term LBMC 
were established from VDJoEt~C~ transgenic lines 5, 5.1, and 
2, VDJt~E~C, line 382, and VDJt~C~ line 1010. The LBMC 
were propagated in media supplemented with recombinant 
human II.-7 (19-21) for 1 wk to expand immature pre-B cells. 
Nonadherent cells harvested from the LBMC were determined 
to represent pre-B cells based on expression of various  sur- 
face markers and of RAG-1 and -2 transcripts (data not shown 
and reference 23).  A-MuLV transformed B cell lines were 
established from bone marrow of VDJt~EoC~, transgenic line 
5.1, VDJaE~C~ line 382, and VDJt~C, line 1016 (24). These 
cell lines also were determined to represent pre-B cells based 
on expression of characteristic surface markers, rearrangement 
of endogenous IgH loci, and expression  of RAG-1 and -2 
transcripts (data not shown). 
We readily detected DJ, but not V(D)J construct rearrange- 
ments by Southern blotting analyses of DNA from LBMC 
and A-MuLV transformed cell lines established  from the 
VDJaEt~C~ and VDJoE,C, transgenic lines (Fig. 2, C lanes 
3, 6, 9, 12, 13, and 14; and Table 1). In contrast, neither DJ 
nor VDJ rearrangements were detected by a similar analysis 
of DNA from VDJoC~ transgenic A-MuLV transformants 
(Fig. 2 C, lanes 17-19).  We also assayed for construct DJ 
and V(D)J rearrangements in DNA from the various LBMC 
and A-MuLV pre-B cell lines by the more sensitive PCK 
method to detect potential construct rearrangements that oc- 
curred below the detection level of the Southern blotting assay. 
Thymus and liver DNA samples from the corresponding lines 
again were used as controls. Even with this sensitive assay, 
we could not detect rearrangements of the VDJ~C, substrate 
in DNA from LBMC and A-MuLV transformed cell lines 
generated from VDJ~C,  transgenic mice (Fig.  3  C,  line 
1010; Fig. 3 D, line 1016). In contrast, substantial levels of 
DJ substrate rearrangement, comparable to that of the corre- 
sponding thymic DNA,  were detected in DNA  from all 
LBMC and A-MuLV-transformed cell lines established from 
VDJ~EoC~  and  VDJ~E~C,  transgenic  mice  (Fig.  3  C). 
However, we again could not detect significant levels (levels 
were at least  100-fold less than that of the corresponding 
thymus sample) of construct VDJ rearrangements in LBMC 
and only extremely low levels in some A-MuLV transformants 
from VDJoE~C~ and VDJ~E~Cu transgenic mice (Fig. 3, C 
and D). 
Enhancer Dependent Transcription of the Unrearranged Con- 
struct D-J~ Region in B Lineage Cells.  To quantify expres- 
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sion of transcripts from the D-J~ portion of the transgenic 
recombination substrates,  we employed an S1 nuclease pro- 
tection assay that used a probe which included the D-J~ 
and Eft regions of the VDJ~EaC~ construct (Fig. 4 A, top). 
A combination of $1 nuclease protection and primer exten- 
sion analyses of thymic R.NA from VDJ~E~C~ transgenic 
mice indicated that transcripts initiate from multiple sites 
in the region of the construct between the D  and J~l seg- 
ment (Ferrier, P., and F. Alt, unpublished data).  Thus, hy- 
bridization of transcripts that span the entire region of the 
probe will result in a 950-bp protected fragment in RNA 
from VDJ~E~C~ transgenic lines and a 490-bp fragment in 
KNA derived from VDJflE~C~ or VDJ~C~ lines,  whereas 
transcripts that initiate internal to the probe protect a series 
of smaller fragments. Potential transcripts from VDJ~EflC~ 
DJ~I  or DJ~2 rearrangements would protect probe frag- 
ments of 870 or 740 bp whereas those from VDJ~E~C~ or 
VDJ~C~ rearrangements would protect fragments of 310 or 
180 bp.  As  a  control,  we  also  quantitated expression of 
glyceraldehyde-3-phosphate  dehydrogenase (GAPDH) tran- 
scripts  simultaneously or in parallel  (Fig. 4 B). 
We did not detect transcripts of the unrearranged construct 
D-J region in KNA from thymus, liver, LBMC, or A-MuLV 
transformants derived from VDJ~C~ transgenic animals (ref- 
erence 9 and Fig. 4 B, top; lanes 5-9).  In contrast, we de- 
tected D-J region construct transcripts in KNA from thymus, 
LBMC and A-MuLV transformants, but not liver, from both 
VDJ~E~C~ and VDJflE~C~ transgenic mice (Fig. 4 B,  top; 
lanes 2-4,  10-15,  and 18-24).  Thus, DNA fragments con- 
taining either the E~ or E~ enhancers activate transcription 
through the De and J~ portion of the transgenic minilocus 
in both pre-B  cells and thymocytes. 
Enhancer-dependent Transcription of Unrearranged Substrate 
V# Segments in B Lineage Cells.  We employed a probe span- 
ning the 3' end of the construct V~14 segment (Fig.  4 B, 
bottom) in $1 nuclease protection assays to detect transcripts 
derived from this portion of the transgenic constructs; this 
probe detects transcripts from unrearranged and rearranged 
V~14 segments as protected fragments of 340 and 90 bp 
(Fig. 4 A, bottom). Because this probe does not distinguish 
between construct-derived and endogenous Va-containing 
transcripts; transgene expression is detected by quantitative 
comparison of transcript levels in corresponding RNA samples 
from transgenic and nontransgenic sources (9). 
We detected transcripts of germline and rearranged V014 
segments at levels well above nontransgenic background in 
RNA from thymus, but not liver, of all mice transgenic for 
VDJt3E~C~ or VDJaE~C~ constructs (Fig. 4 B, bottom, lanes 
2-4, 10-15, and 18-24).  In contrast, we did not detect levels 
of V~14 transcripts in thymus R.NA of VDJ~C~ transgenic 
mice above those of nontransgenic mice (reference 9,  Fig. 
4 B, bottom, lanes 5-9 and data not shown). Thus, the E~ 
enhancer, like the Eu enhancer (9), can activate transcription 
of the unrearranged construct Va segment in thymocytes. 
Surprisingly, purified peripheral B cells from VDJoEuC~ or 
VDJ~E~C~ mice expressed  levels of Vf114 transcripts that 
were reproducibly as high or higher than those found in RNA 
from the corresponding thymuses (Fig. 4 C). To determine Figure 4.  Expression  of the transgenic recombination  substrates. (.4) (~p): Schematic  of $1 probes used to detect transcripts from the minilocus 
D-J regions. Other details concerning  construct-specific  transcripts are in the results section. Although  transcripts  of endogenous  DJg or VDJ6 rear- 
rangements would protect 310 and 180 bp fragments of this probe, we could not unequivocally  identify  the presence of these transcripts except in 
normal thymic  RNA (data not shown). (Bottom): the probe to detect  V~14 transcripts; sizes of protected fragments  resulting  from transcripts  of rear- 
ranged or unrearranged sequences  are indicated. Other details are in the methods  or results section. (B) Transcripts of the D-J (top) and V~14 (bottom) 
regions of the recombination  substrate in tissues  and cell lines generated  from transgenic  mice. 10/xg of total RNA from indicated  sources were simul- 
taneously  assayed  for hybridization  to the substrate  DJ region  (top) and GAPDH (middle) probes; hybridization  to the V~14 probe (bottom) was assayed 
in with duplicate  RNA samples. Bands  corresponding  to unrearranged  and rearranged D-J transcripts and unrearranged  Va14 segments  are indicated. 
Bands corresponding to undigested  probe in V~14 protection assays  are denoted. (C) Transcripts of the Va14 region of the recombination  substrate 
in long-term  LBMC and purified  B cells from transgenic  mice. Approximately  2/xg of total RNA was assayed  from thymus,  liver, non-adherent  cells 
from long-term  LBMC  and purified  B cells were assayed  for transcription  of the unrearranged V~14 segment. Transcription  of GAPDH was assayed 
simultaneously. 
whether  the V~ portion  of these  transgenes was  also  ex- 
pressed in pre-B cells, we assayed RNA from LBMC. Again, 
we  reproducibly  detected  unrearranged  V~14 gene  tran- 
scripts  in LBMC (cultured with or without added IL-7) es- 
tablished from all tested VDJ~E,C~ or VDJ~EaC, lines  at 
levels that often approached those of the corresponding thymic 
RNA; these transcripts were enhancer dependent as none were 
detected in LBMC established from VDJoC, transgenic mice 
(with IL-7, Fig. 4 B  bottom, lanes 6, 12, 20, and 24; without 
IL-7, Pig. 4 C, lane 3). Because the V~ expression  levels in 
cultured pre-B, peripheral B, and thymic T cells from a given 
transgenic line were roughly proportional to VDJaE,  C, and 
VDJaEaC~ copy numbers (which range from a few to about 
100), it also would appear that most copies of the transgene 
are expressed  in each of these cell types (see Fig. 4, B and 
C). As with VDJ~E~Cg mice (9),  we could not readily de- 
tect V~3 transcripts in total bone marrow of the VDJ~EoC, 
mice (data not shown). Assuming that normal pre-B  cells 
express this transcript at the same level as those in LBMC, 
the  difficulty in  detecting  these  transcripts  in  total bone 
marrow is consistent with the low level of B lineage cells 
in this tissue (28). 
Analyses  of V~14 expression  in A-MuLV transformants 
derived from the various transgenic lines yielded results that 
were generally in accord with those obtained from normal 
B lineage cells. Thus, we also detected unrearranged V~14 
transcripts in VDJ~EuCu and VDJaE~C~ A-MuLV transfor- 
mants (see Fig. 4 B). However, the expression level of these 
transcripts often was lower than that of the corresponding 
LBMC culture (see Fig. 4 B), possibly due to downregula- 
tion of transgene expression in these transformed lines. Down- 
regulation of the expression of some endogenous lymphoid- 
specific genes has been clearly documented in such lines (29). 
We did not detect unrearranged V~14 transcripts in RNA 
from nontransgenic A-MuLV transformants (see Fig.  4 B, 
lanes 16 and 17). We also did not detect these transcripts in 
2  of 3  tested  A-MuLV  transformants from  the  VDJ~C~ 
transgenic line; in the other line they occurred at extremely 
low levels (see Fig. 4 B, lanes  7-9). 
We did not detect protected fragments that clearly cor- 
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from LBMC or peripheral B cells. However, we occasionally 
observed protected fragments that migrated roughly at this 
size (80 bp) in some LBMC sample (data not shown). The 
latter fragments were likely artifactual due to probe or RNA 
degradation because they usually were not found in repeat 
experiments with samples from the same source and because 
there were no detectable Vfl rearrangements in the DNA 
from these sources. On the other hand, we did detect very 
low  but  reproducible  levels of protected fragments that 
corresponded  to rearranged Va  transcripts  in RNA from 
A-MuLV transformants derived from VDJflE~C~ mice; these 
probably  derived from the low level of construct V~ rear- 
rangements found in these cell lines (Fig. 3 C). 
]~scuss~on 
The Minimal  TCR-fl Enhancer Activates D  to J  TCR-fl 
Minilocus Rearrangements in B and T Lineage Cells.  We have 
demonstrated that addition of the minimal TCR-fl enhancer 
region to the VDJ~C~, construct activates its  transcription 
and rearrangement in developing B and T lineage cells in a 
fashion essentially identical to that which we previously ob- 
served for a larger DNA fragment that contains the E/z de- 
ment.  The  "core" E~,  and Ea dements are unrelated;  al- 
though the E~,-containing sequence employed in our earlier 
studies contained one site, gEBP-E (30-32) also found in the 
core E~ dement. 
The ability of both the E. and E~ enhancer elements to 
direct rearrangement of the TCP.-fl minilocus in a c/s-dominant 
fashion suggests that these and other Ig or TCP.. transcrip- 
tional enhancers may function as "recombination" enhancers 
in their endogenous setting. Accordingly, recent gene-targeted 
mutation studies demonstrated that deletion or replacement 
of the endogenous E~ dement significantly reduced the rear- 
rangement level of the  associated Jr~  segments (33, 34). 
However,  the E~ deletion did not eliminate Jr~ rearrange- 
ments. Therefore,  it  is likely that  the VDJflC.  construct 
lacks additional dements present in the endogenous IgH locus 
that promote rearrangement independently from the E. de- 
ment but that may act synergistically with E. to confer full 
V(D)J  recombinational  accessibility. Thus,  the  VDJ~C. 
minilocus  should provide a system to identify and further 
characterize such dements. 
Enhancer-dependent Transcriptional  Activation of the Minilocus 
Recombination Substrate.  The unrearranged V~14 segment 
and the D-J~ portion of the VDJ~E~Cg and VDJ~EaC. but 
not VDJ~C~ transgenes are transcribed in both T and B lin- 
eage ceils. Thus, the generation of both types of transcripts 
is enhancer-dependent.  Correspondingly,  the E~ and E~ ele- 
ments can activate multiple promoters over long distances 
in B and T lineage cells (31, 35-39).  Notably,  the endoge- 
nous TCR D-J~ locus and V~14 gene segment generally are 
transcribed in T but not B lineage cells. Therefore, transcrip- 
tion of these regions of the TCK-fl locus are differentially 
regulated in the minilocus  vs. the endogenous locus, even 
in the context of the E~ element. As the V~14 segment is 
further from the Ea element in the transgene than in the en- 
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dogenous locus, it is unlikely that distance effects with re- 
spect to these sequences are responsible for transcriptional 
activation in B cells. Thus, as previously proposed (31, 36), 
endogenous elements  in  addition to  the core E~ element 
likely contribute to T  cdl-specific transcription of V~ and 
D-J0 sequences. 
Potential Relationships between Transc@tional Activation and 
V(D)J Recombinational Accessibility.  Transcription  has been 
shown to promote homologous recombination (40-42). Like- 
wise, V(D)J recombinational accessibility of endogenous and 
stably transfected variable region gene segments has been cor- 
related both with transcription  (6, 7, 12, 43, 44) and with 
the cis-acting functions of transcriptional enhancer elements 
(9, 25, 45; this study). However, with respect to V(D)J recom- 
bination, the nature of the relationship between these processes 
has remained unclear. The recombinational  enhancement of 
DJ~ rearrangements conferred by the two different enhancer 
elements in our substrates again correlates well with their 
transcriptional  enhancement of the same region of the sub- 
strate. However, our data suggest a surprising dichotomy be- 
tween V~14 transcription  and rearrangement in B lineage 
cells. 
We detected essentially no rearrangements of the V~14 
segments  of VDJ~E~C~, or VDJ~E~,Co transgenes  in  any 
normal B lineage cells. Yet, we dearly detected transcription 
of the unrearranged substrate V~14 segment in both early 
and late-stage B lineage cells. These results indicate that en- 
hancer dependent transcription  of the minilocus Vf114 seg- 
ment occurs throughout all stages of early B cell develop- 
ment, including stages that undergo V(D)J recombination 
of endogenous Ig loci. Several  lines of evidence indicate that 
the transcripts that we have detected originate from the com- 
plete transgene substrate, rather than an aberrantly integrated 
copy. Thus, the transcripts are lymphocyte-specific  (indicating 
enhancer dependence) and correspond in steady-state level in 
the various lines in rough proportion to the transgene copy 
number of the line. 
Thus, our current studies make the unexpected and novel 
observation that a transcribed variable region gene segment 
still may not be accessible to V(D)J recombinase, indicating 
that, at least in some contexts, transcription  per se of a vari- 
able region gene segment is not sufficient  to promote its recom- 
binational accessibility. A similar situation apparently exists 
with respect to control of Ig heavy chain class switch recom- 
bination;  gene targeted mutations that generate constitutive 
transcription  through the Ig C~ switch recombination se- 
quences do not promote significant levels of switching to that 
region in appropriately  activated B ceils (46). 
The potential relationship between transcriptional activa- 
tion and recombinational  accessibility has also been the sub- 
ject of studies that have taken the converse approach of as- 
saying  for  rearrangement  of  apparently  nontranscribed 
substrates. Transiently transfected recombination substrates 
were shown to recombine in the absence of transcriptional 
control dements and steady-state transcripts (47). However, 
such observations may not be directly relevant to normal con- 
trol mechanisms, as genes on small extra chromosomal sub- 
strates are likely subject to different regulatory constraints than chromosomally integrated genes. In another study, trans- 
genic V~ and J~ segments were found to rearrange in the ab- 
sence of detectable steady-state transcripts from the recombi- 
nation substrates (48); but levels of detected rearrangements 
were very low, the absence of transcription was not directly 
demonstrated, and assays were done only in mature B lin- 
eage cells. Therefore, there still is no compelling evidence 
that a chromosomal locus can undergo effcient V(D)J recom- 
bination in the absence of transcriptional activation and/or 
transcriptional control elements. 
Several studies have shown that accessibility is strongly cor- 
related with hypomethylation of substrate loci (49-51).  Due 
to the lack of informative restriction endonuclease sites, we 
could not directly address  this issue with respect  to the Va 
gene segment portion of our constructs. However, as tran- 
scribed genes are usually hypomethylated (52), we would ex- 
pect this to be the case for the Va and DJt~ regions of our 
construct in both B and T lineage cells. Even so, recent tar- 
geted mutational analyses of the Eu element and flanking se- 
quences  indicated that  hypomethlyation also  may not be 
sufficient to render the endogenous JH locus fully accessible 
for V(D)J recombination (34). 
In summary, it appears that, at least in some contexts, nei- 
ther transcriptional activation nor hypomethylation of chro- 
mosomal variable region gene segments is sufficient to render 
them fully accessible for V(D)J recombination. Conversely, 
efficient rearrangement of nontranscribed or methylated chro- 
mosomal variable region gene segments has not been clearly 
documented. Thus, it remains possible,  and even likely, that 
transcription and/or transcriptional enhancing element plus 
demethylation may be necessary companions of full V(D)J 
recombinational accessibility; but that additional factors fur- 
ther modulate the control of this process in some contexts. 
Differential  Control of D  to J  and  V  to  DJ  Rearrange- 
ments.  Various lines of evidence indicate that, for both Ig 
and TCR loci, V to DJ rearrangement is the most strictly 
regulated V(D)J recombination event, both in the context 
of tissue specificity and allelic exclusion (12-14,  53). Unlike 
many other test systems, this aspect of normal control is dearly 
reproduced in our transgenic recombination substrates,  pos- 
sibly due to the composition of the construct and/or its rela- 
tively large size (which may obviate position effects). In this 
regard, our current findings are consistent with a model in 
which D  and J  recombination events  are promoted by E~ 
functions identical to or closely associated with its transcrip- 
tional enhancing activities whereas the more stringently regu- 
lated V to DJjoining event may be influenced by additional 
positive or negative control elements that ensure appropriate 
specificity. 
We thank Dr. Pierre Ferrier for generation of the VDJaEaC, construct and for his advice and assistance 
during this work. We also thank A. Stall and D. Ahem for help with FACS  |  analysis; (3. Rathbun, R. 
Lansford, B. Malynn, and especially  E. Oltz for critically reading the manuscript. We thank Dr. S. Gillis 
for providing recombinant IL-7. 
This work was supported by the Howard Hughes Medical Institute and by National Institutes of Health 
grants AI-20047 and AI-31541 to F. W. Alt, 
Address correspondence  to Dr. Frederick W. Alt, Department of  Genetics, Howard Hughes Medical Insti- 
tute,  the Children's Hospital, 300 Longwood Avenue, Boston, MA 02115. 
Received for publication 26 October 1993 and in revised  form  9 February 1994. 
References 
1.  Tonegawa, S. 1983. Somatic generation of antibody diversity. 
Nature (Lond.). 302:575. 
2.  Chert, J., and EW. Alt. 1993. Gene rearrangement and B-cell 
development. Cu~  Opin. Immunol. 5:194. 
3.  Alt, F.W., E.M. Oltz, F. Young, J. Gorman, G. Taccioli, and 
J. Chen.  1992. VDJ recombination. Immunol. Today. 13:306. 
4.  yon Boehmer, H. 1988. The developmental  biology ofT lym- 
phocytes. Annu. Rev. lmmunol. 6:309. 
5.  Kronenberg, M., G. Siu, L. Hood, and N. Shastri. 1986. The 
molecular genetics of the T-cell antigen receptor and T-cell an- 
tigen recognition. Annu.  Rev. Immunol. 4:529. 
6.  Yancopoulos,  G.D., and F.W. Alt. 1986. Regulation of the as- 
sembly and expression of variable-region genes. Annu, R~ Im- 
munol. 4:339. 
7.  Blackwell, T.K., M.W. Moore, G.D. Yancopoulos, H. Suh, 
S. Lutzker, E. Selsing, and F.W. Alt. 1986. Recombination be- 
tween immunoglobulin variable region gene segments is en- 
hanced by transcription. Nature (Lond.). 324:585. 
8.  Yancopoulos, G.D., T.K. Blackwell, H. Suh, L. Hood, and 
F.W. Alt. 1986. Introduced T cell receptor variable  region gene 
segments recombine in pre-B cells: evidence  that B and T cells 
use a common recombinase. Cell. 44:251. 
9.  Ferrier, P., B. Krippl, T.K. Blackwell, A.J. Furley, H. Suh, 
A. Winoto, W.D. Cook, L. Hood, F. Costantini, and F.W. 
Aft. 1990. Separate elements control DJ and VDJ rearrange- 
ment in a transgenic  recombination  substrate. EMBO (Fur. Mol. 
Biol. Organ.).]. 9:117. 
10.  Schlissel, M.S., and D. Baltimore. 1989. Activation of immu- 
noglobulin kappa gene rearrangement correlates with induc- 
tion of germline kappa gene transcription. Cell. 58:1001. 
270  Differential  Activation of Transcription vs. Transgenic V(D)J Recombination 11.  Schlissel, M.S., A. Voronova, and D. Baltimore. 1991. Helix- 
loop-helix transcription factor E47 activates germline immu- 
noglobulin heavy-chain gene transcription and rearrangement 
in a pre-T cell line.  Genes & Dev. 5:1367. 
12.  Anderson, S.J., K.M. Abraham, T. Nakayama, A. Singer, and 
R.M. Perlmutter. 1992. Inhibition ofT-cell receptor beta chain 
gene rearrangement by overexpression of the nonreceptor pro- 
tein tyrosine kinase  p561ck.  EMBO (Eur. Mol. Biol. Organ.) 
J.  11:4877. 
13.  Alt, F.W., G.D. Yancopoulos,  T.K. Blackwell,  C. Wood, E. 
Thomas, M. Boss, R. Coffman, N. Rosenberg, S. Tonegawa, 
and D. Baltimore. 1984. Ordered rearrangement of immuno- 
globulin heavy chain variable region segments. EMBO (Eur. 
Mol. Biol. Organ.) J.  3:1209. 
14.  Uematsu, Y., S. Ryser, Z. Dembic, P. Borgulya, P. Krimpen- 
fort, A. Berns, H. von Boehmer, and M. Steinmetz. 1988. In 
transgenic mice the introduced functional T  cell receptor 
gene prevents expression of endogenous/$ genes. Cell. 52:831. 
15.  van Meerwijk, J.P.M., H. Bluthmann, and M. Steinmetz. 1990. 
T-cell specific rearrangement of T-cell receptor ~  transgenes 
in transgenic mice. EMBO (Eur. Mol. Biol. Organ.)  J. 9:1057. 
16.  Ferrier, P., L.R. Covey, H. Suh, A Winoto, L. Hood, and F.W. 
Alt.  1989.  T  cell receptor DJ but not VDJ rearrangement 
within a recombination substrate introduced into a pre-B cell 
line.  Int. Immunol.  1:66. 
17.  Wysocki, L.J., and V.L. Sato.  1978. "Panning" for lympho- 
cytes: A method for cell selection.  Proc. Natl. Acad. Sci. USA. 
75:2844. 
18.  Whitlock,  C.,  and  O.  Witte.  1982.  Long-term culture of 
B-lymphocytes and their precursors from routine bone marrow. 
Proa Natl.  Acad. Sci. USA.  79:3608. 
19.  Morrow, M.A., G. Lee, S. Gillis, G.D. Yancopoulos, and F.W. 
Alt. 1992. Interleukin-7 induces N-myc and c-myc expression 
in normal precursor B lymphocytes. Genes & Dev. 6:61. 
20.  Goodwin, R.G., S. Lupton, A. Schmierer,  K.J. Hjerrild, R. 
Jerzy, W.  Clevenger,  S. Gillis, D. Cosman,  and A. Namen. 
1989. Human interleukin 7: Molecular cloning and growth 
factor activity on human and murine B-lineage cells. Proa Natl. 
Acad. Sci. USA.  86:302. 
21.  Lee, G., A.E. Namen, S. Gillis, L.R. Ellingsworth, and P.W. 
Kincade. 1989. Normal B cell precursors responsive to recom- 
binant murine IL-7 and inhibition of ILo7 activity by trans- 
forming growth factor-b1. J. Immunol. 992:3875. 
22.  Hardy, R.R., C.E. Carmack, S.A. Shinton, J.D. Kemp, and 
K. Hayakawa.  1991. Resolution and characterization of pro-B 
and pre-pro-B cell stages in normal mouse bone marrow. J. 
Exp. Med. 173:1213. 
23.  Li, Y.-S., K. Hayakawa,  and R.R.  Hardy. 1993. The regu- 
lated expression of B lineage  associated  genes  during B cell 
differentiation in bone marrow and fetal liver. J. Exp. Med. 
178:951. 
24.  Rosenberg, N., and D. Baltimore. 1976. A quantitative assay 
for transformation of bone marrow cells by Abelson murine 
leukemia virus. J. Exp. Ailed. 143:1453. 
25.  Oltz, E.M., F.W. Alt,  W.-C.  Lin, J.  Chen,  G. Taccioli, S. 
Desiderio, and G. Rathbun.  1993. A V(D)J recombinase in- 
ducible B cell line:  role of transcriptional enhancer elements 
in directing V(D)J recombination. Mol. Cell. Biol. 13:6223. 
26.  Zhang, J., A. Bottaro, S. Li, V. Stewart, and F.W. Alt. 1993. 
A selective defect in IgG2b switching as a result of targeted 
mutation of the I3/2b promoter and exon. EMBO (Eur. Mol. 
Biol. Organ.) J.  12:3529. 
27.  Gallard,  F., M. Stefanova, V. Pirisi,  and D. Birnbaum. 1990. 
Characterization of a murine glyceraldehyde-3-phosphate de- 
hydrogenase pseudogene. Biochemie (Paris). 72:759. 
28.  Osmond, D.G. 1990. B cell development in the bone marrow. 
Semin. Immunol. 2:173. 
29.  Rathbun,  G., F.W. Alt, and E.M.  Oltz.  1993.  Comparison 
of RAG gene expression in normal and transformed precursor 
lymphocytes. Int. Immunol. 5:997. 
30.  Peterson, C.L., and K. Calame, 1987. Complex protein binding 
within the mouse immunoglobulin heavy-chain enhancer. Mol. 
Cell. Biol. 7:4194. 
31.  Takeda, J., A. Cheng, F. Manxion, C.A. Nelson, R.D. New- 
berry, W.C. Sha, R. Sen, and D.Y. Loh. 1990. Functional anal- 
ysis of the murine T-cell receptor ~ enhancer and characteris- 
tics of its DNA-binding proteins. Mol. Cell. Biol. 10:5027. 
32.  Peterson, C.L., S. Eaton, and K. Calame.  1988. Purified mu 
EBP-E binds to immunoglobulin enhancers and promoters. Mol. 
Cell. Biol. 8:4972. 
33.  Serwe,  M., and F. Sablitzky.  1993.  V(D)J recombination in 
B cells is impaired but not blocked by targeted deletion of the 
immunoglobulin heavy chain intron enhancer.  EMBO (Eur. 
Mol. Biol. Organ.)  J.  12:2321. 
34.  Chen, J., F. Young, A. Bottaro, u  Stewart, R.K. Smith, and 
F.W. Alt. 1993. Mutations of the intronic Ig enhancer and its 
flanking sequences  differentially affect accessibility  of the J. 
locus. EMBO (Eur. Mol. Biol, Organ.) J.  12:4635. 
35.  Krimpenfort, P., R. deJong, Y. Uematsu, Z. Dembic, S. Ryser, 
H. yon Boehmer, M. Steinmetz, and A. Berns. 1988. Tran- 
scription of T  cell receptor B-chain genes is controlled by a 
downstream regulatory element. EMBO (Fur. Mol. Biol. Organ.) 
J.  7:745. 
36.  McDougall, S., C.L. Peterson, and K. Calame.  1988. A tran- 
scriptional enhancer 3' of C beta 2 in the T cell receptor beta 
locus.  Science (Wash. DC).  241:205. 
37.  Staudt, L., and M. Lenardo. 1991. Immunoglobulin gene tran- 
scription. Annu.  Rev. Imrnunol. 9:373. 
38.  Libermann, T., and D. Baltimore. 1991. Transcriptional regu- 
lation  of immunoglobulin  gene  expression.  In  Molecular 
Aspects of Cellular Regulation,  vol. 6.  P.  Cohen and J.G. 
Foulkes,  editors.  Elsevier Science Publishing Co., Inc., New 
York.  399-421. 
39.  Atchison, M. 1988. Enhancers: Mechanisms ofaction and cell 
specificity. Annu.  Rev. Cell. Biol. 4:127. 
40.  Voelkel-Meiman,  K.,  R.L.  Keil,  and  G.S.  Roeder.  1987. 
Recombination-stimulating sequences in yeast ribosomal DNA 
correspond to sequences regulating transcription by RNA poly- 
merase  I.  Cell. 48:1071. 
41.  Thomas, B.J., and R.  Rothstein.  1989. Elevated recombina- 
tion rates  in transcriptionally active DNA.  Cell. 56:619. 
42.  Nickoloff, J.A., and R.J. Reynolds. 1990. Transcription stimu- 
lates homologous recombination in mammalian cells. Moll. Cell. 
Biol. 10:4837. 
43.  Yancopoulos, G.D., and F.W. Alt. 1985. Developmentally con- 
trolled and tissue-specific expression of unrearranged VH gene 
segments.  Cell. 40:271. 
44.  Goldman, J.P., D.M.  Spencer,  and D.H.  Raulet.  1993.  Or- 
dered rearrangement of variable  region genes of the T  cell 
receptor 3/locus correlates with transcription of the unrear- 
ranged genes. J. Exp. Med. 177:729. 
45.  Engler, P.,  P.  Roth, J.Y. Kim,  and U.  Storb.  1991. Factors 
affecting the rearrangement efficiency of an Ig test gene.J. Im- 
munol. 146:2826. 
46.  Bottaro, A., R. Lansford, L. Xu, J. Zhang, P. Rothman, and 
F.W. Alt.  1994. S region transcription per se promotes basal 
271  Okada  et al. IgE class switch recombination but additional factors regulate 
the efficiency of the process. EMBO (Eur. Mol. Biol. Organ.) 
J.  13:665. 
47.  Hsieh, C.L., R.P. McCloskey, and M.K. Lieber. 1992. V(D)J 
recombination on minichromosomes is not affected by tran- 
scription. J. Biol, Chem.  267:15613. 
48.  Kallenbach,  S., C. Babinet, S. Pournin, P. Cavelier, M. Good- 
hardt, and F. Kougeon. 1993. The intronic immunoglobulin 
gene enhancer acts independently on rearrangement and on 
transcription. Eur. J. Immunol.  23:1917. 
49.  Hsieh, C.L., and M.R. Lieber.  1992. CpG methylated mini- 
chromosomes become inaccessible  for V(D)J recombination 
after undergoing replication. EMBO (Eur. Mol. Biol. Organ.) 
j.  182:125. 
50.  Engler, P., D. Haasch, C.A. Pinkert, L. Doglio, M. Glymour, 
K. Brinster, and U. Storb. 1991. A strain-specific modifier on 
mouse chromosome 4 controls the methylation of indepen- 
dent transgene loci. Cell. 65:939. 
51.  Goodhardt,  M.,  P.  Cavelier,  N.  Doyen, S.  KaUenbach,  C. 
Babinet, and E Rougeon. 1993. Methylation status ofimmu- 
noglobulin ic gene segments correlates with their recombina- 
tion potential. Eur. J. Immunol.  23:1789. 
52.  Cedar, H. 1988. DNA methylation and gene activity. Cell. 53:3. 
53.  Anderson, S.J., S.D. Levin, and R.M. Perlmutter. 1993. The 
protein tyrosine kinase p561ck controls allelic exclusion of T 
cell receptor/3 chain genes.  Nature (Lond.). 365:552. 
54.  Lenardo,  M. J.W.  Pierce,  and D.  Baltimore.  1987.  Protein- 
binding sites in Ig gene enhancers determine transcriptional 
activity and inducibility. Science (Wash. DC).  236:1573. 
55.  Oltz, E.M.,  G.D. Yancopoulos,  M.A.  Morrow, A.  Rolink, 
G. Lee, F. Wong, K. Kaplan,  S. Gillis, E  Melchers,  and F.W. 
Alt. 1992. A novel regulatory myosin light chain gene distin- 
guishes  pre-B cell subsets  and is IL-2 inducible.  EMBO (Eur. 
Mol. Biol. Organ.).].  11:2759. 
272  Differential  Activation of Transcription vs. Transgenic V(D)J Recombination 